{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T03:01:23Z","timestamp":1789441283583,"version":"build-2803163510"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"31","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8,1]]},"abstract":"<jats:p>This work aimed to study neuropsychiatric (NP) events related to systemic lupus erythematosus (SLE) in an Asian African cosmopolitan cohort attending a tertiary care university hospital. Medical records of 312 adults with SLE were retrospectively revised. Patients\u2019 from 14 Asian and 13 African countries were subgrouped according to the presence of NP manifestations. Electromyography and nerve conduction studies (EMG\/NCS), electroencephalogram (EEG), computerized tomography and magnetic resonance imaging brain were considered. The systemic lupus international collaborating clinics damage index (SLICC-DI) was assessed. Patients were 275 females and 37 males (7.4:1), mean age 37.5\u2005\u00b1\u200512.7 years and disease duration 5.2\u2005\u00b1\u20053.2 years. 242 were Asian (150 Saudis) and 70 African. 279 were adult-onset, 26 juvenile-onset and 7 elderly-onset. NP manifestations were present in 48.4%. In NPSLE, magnetic resonance imaging brain showed white matter lesions (11.3%), infarction (9.9%), posterior reversible encephalopathy syndrome (5.2%),brain atrophy (1.3%) and vasculitis (2.6%); electromyography and nerve conduction studies revealed polyneuropathy (11.9%) and electroencephalogram epileptical changes in 3.3%. In NPSLE, lupus nephritis, receiving rituximab, SLICC-DI and mortality were significantly higher (53%, 16.6%, 1.94\u2005\u00b1\u20051.9 and 19.2% vs 36.6%, 8.1%, 0.54\u2005\u00b1\u20051.04 and 8.7%; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.004, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.02, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.0001 and <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.008 respectively). NP manifestations were similar between Asians and Africans (47.1% vs 52.9%; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.4). SLICC-DI was significantly lower in Saudis (0.88\u2005\u00b1\u20051.28) compared to non-Saudis (1.53\u2005\u00b1\u20051.91; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.001). NP involvement is frequent in SLE patients especially females and is related to renal affection. Damage, mortality and receiving rituximab were significantly higher in those with NP manifestations. NP events are similar between Asian and African patients and damage in Saudis was remarkably less.<\/jats:p>","DOI":"10.1097\/md.0000000000043617","type":"journal-article","created":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T23:01:00Z","timestamp":1754089260000},"page":"e43617","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Neuropsychiatric systemic lupus erythematosus events: An Asian African cosmopolitan study in a tertiary care university hospital"],"prefix":"10.1097","volume":"104","author":[{"given":"Hind","family":"Alnajashi","sequence":"first","affiliation":[{"name":"Neurology Department, King Abdulaziz University, Jeddah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3507-781X","authenticated-orcid":false,"given":"Ibtisam","family":"Jali","sequence":"additional","affiliation":[{"name":"Internal Medicine and Rheumatology Department, King Abdulaziz University, Jeddah, Saudi Arabia."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250918","first-page":"5899188","article-title":"Neuropsychiatric lupus and lupus nephritis successfully treated with combined IVIG and rituximab: an alternative to standard of care.","volume":"2022","author":"Cheikh","year":"2022","journal-title":"Case Rep Rheumatol"},{"key":"R2-20250918","first-page":"997","article-title":"Systemic lupus erythematosus: one year in review 2023.","volume":"41","author":"Zucchi","year":"2023","journal-title":"Clin Exp Rheumatol"},{"key":"R3-20250918","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/WCO.0000000000000822","article-title":"Advanced neuroimaging in neuropsychiatric systemic lupus erythematosus.","volume":"33","author":"Mackay","year":"2020","journal-title":"Curr Opin Neurol"},{"key":"R4-20250918","doi-asserted-by":"crossref","first-page":"e000895","DOI":"10.1136\/rmdopen-2019-000895","article-title":"Performance of the proposed ACR-EULAR classification criteria for systemic lupus erythematosus (SLE) in a cohort of patients with SLE with neuropsychiatric symptoms.","volume":"5","author":"Gegenava","year":"2019","journal-title":"RMD Open"},{"key":"R5-20250918","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.3390\/jcm11174955","article-title":"Progress in the pathogenesis and treatment of neuropsychiatric systemic lupus erythematosus.","volume":"11","author":"Wang","year":"2022","journal-title":"J Clin Med"},{"key":"R6-20250918","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/BOR.0000000000000682","article-title":"Advances in the diagnosis, pathogenesis and treatment of neuropsychiatric systemic lupus erythematosus.","volume":"32","author":"Moore","year":"2020","journal-title":"Curr Opin Rheumatol"},{"key":"R7-20250918","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3389\/fmed.2019.00052","article-title":"Editorial: lupus and the brain: advances in neuropsychiatric systemic lupus erythematosus.","volume":"6","author":"Fanouriakis","year":"2019","journal-title":"Front Med (Lausanne)"},{"issue":"Suppl5","key":"R8-20250918","doi-asserted-by":"crossref","first-page":"v52","DOI":"10.1093\/rheumatology\/keaa404","article-title":"The management of neuropsychiatric lupus in the 21st century: still so many unmet needs?","volume":"59","author":"Govoni","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"R9-20250918","doi-asserted-by":"crossref","first-page":"101893","DOI":"10.1016\/j.berh.2023.101893","article-title":"Systemic lupus erythematosus and damage: what has changed over the past 20 years?","volume":"37","author":"Mu\u00f1oz\u2011Grajales","year":"2023","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"R10-20250918","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/head.14501","article-title":"Headache and systemic lupus erythematosus: a narrative review.","volume":"63","author":"de Oliveira","year":"2023","journal-title":"Headache"},{"key":"R11-20250918","doi-asserted-by":"crossref","first-page":"998328","DOI":"10.3389\/fcell.2022.998328","article-title":"Pathogenesis and treatment of neuropsychiatric systemic lupus erythematosus: a review.","volume":"10","author":"Liu","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"R12-20250918","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1093\/rheumatology\/keab823","article-title":"Neuropsychiatric systemic lupus erythematosus is associated with a distinct type and shape of cerebral white matter hyperintensities.","volume":"61","author":"Inglese","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"R13-20250918","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus.","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum"},{"key":"R14-20250918","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/art.1780400506","article-title":"The reliability of the systemic lupus international collaborating clinics\/american college of rheumatology damage index in patients with systemic lupus erythematosus.","volume":"40","author":"Gladman","year":"1997","journal-title":"Arthritis Rheum"},{"key":"R15-20250918","doi-asserted-by":"crossref","first-page":"1111769","DOI":"10.3389\/fneur.2023.1111769","article-title":"The conundrum of neuropsychiatric systemic lupus erythematosus: current and novel approaches to diagnosis.","volume":"14","author":"Emerson","year":"2023","journal-title":"Front Neurol"},{"key":"R16-20250918","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3390\/brainsci12020192","article-title":"Biomarkers in neuropsychiatric systemic lupus erythematosus: a systematic literature review of the last decade.","volume":"12","author":"Lindblom","year":"2022","journal-title":"Brain Sci"},{"key":"R17-20250918","doi-asserted-by":"crossref","first-page":"1098734","DOI":"10.3389\/fpsyt.2023.1098734","article-title":"Prevalence of neuropsychiatric disorders in patients with systemic lupus erythematosus in Pakistan: a systematic review and meta-analysis.","volume":"14","author":"Khan","year":"2023","journal-title":"Front Psychiatry"},{"key":"R18-20250918","doi-asserted-by":"crossref","first-page":"177","DOI":"10.17712\/nsj.2023.3.20220127","article-title":"An evaluation of neuropsychiatric manifestations in systemic lupus erythematosus patients in Saudi Arabia and their associated factors.","volume":"28","author":"Alammari","year":"2023","journal-title":"Neurosciences (Riyadh)"},{"key":"R19-20250918","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2147\/OARRR.S387650","article-title":"Anti-ribosomal-P antibody association with neuropsychiatric lupus in Sudanese patients attending rheumatology clinic in Omdurman military hospital.","volume":"14","author":"Taha","year":"2022","journal-title":"Open Access Rheumatol"},{"key":"R20-20250918","first-page":"1349042","article-title":"Clinical features and outcomes of neuropsychiatric systemic lupus erythematosus in China.","volume":"2021","author":"Zhang","year":"2021","journal-title":"J Immunol Res"},{"key":"R21-20250918","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1177\/0961203320963815","article-title":"Mortality in patients with systemic lupus erythematosus and neuropsychiatric involvement: a retrospective analysis from a tertiary referral center in the Netherlands.","volume":"29","author":"Monahan","year":"2020","journal-title":"Lupus"},{"key":"R22-20250918","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1177\/0961203320908932","article-title":"Evolving phenotype of systemic lupus erythematosus in Caucasians: low incidence of lupus nephritis, high burden of neuropsychiatric disease and increased rates of late-onset lupus in the \u201cAttikon\u201d cohort.","volume":"29","author":"Nikolopoulos","year":"2020","journal-title":"Lupus"},{"key":"R23-20250918","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1093\/rheumatology\/keae119","article-title":"Therapeutic strategies and outcomes in neuropsychiatric systemic lupus erythematosus: an international multicentre retrospective study.","volume":"63","author":"Bortoluzzi","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"R24-20250918","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1177\/0961203320908940","article-title":"Immunological biomarkers in neuropsychiatric systemic lupus erythematosus: a comparative cross-sectional study from a tertiary care center in South India.","volume":"29","author":"Seth","year":"2020","journal-title":"Lupus"},{"key":"R25-20250918","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/1756-185X.12152","article-title":"TULUP (TUnisian LUPus): a multicentric study of systemic lupus erythematosus in Tunisia.","volume":"16","author":"Khanfir","year":"2013","journal-title":"Int J Rheum Dis"},{"key":"R26-20250918","first-page":"33","article-title":"Neuropsychiatric systemic lupus erythematosus among Nigerians.","volume":"38","author":"Adelowo","year":"2009","journal-title":"Afr J Med Med Sci"},{"key":"R27-20250918","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.ejr.2015.09.004","article-title":"Magnetic resonance imaging (MRI) brain abnormalities of neuropsychiatric systemic lupus erythematosus patients in Mansoura city: relation to disease activity.","volume":"37","author":"Zaky","year":"2015","journal-title":"Egypt Rheumatol"},{"key":"R28-20250918","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s41983-022-00464-y","article-title":"Neuropsychiatric lupus erythematosus in a cohort of Egyptian patients.","volume":"58","author":"Ragab","year":"2022","journal-title":"Egypt J Neurol Psychiatry Neurosurg"},{"key":"R29-20250918","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1177\/09612033211014253","article-title":"Adult systemic lupus erythematosus in Egypt: the nation-wide spectrum of 3661 patients and world-wide standpoint.","volume":"30","author":"Gheita","year":"2021","journal-title":"Lupus"},{"key":"R30-20250918","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1177\/0961203308100660","article-title":"Clinical and immunological manifestations in 624 SLE patients in Saudi Arabia.","volume":"18","author":"Al Arfaj","year":"2009","journal-title":"Lupus"},{"key":"R31-20250918","doi-asserted-by":"crossref","first-page":"455","DOI":"10.5606\/ArchRheumatol.2018.6832","article-title":"Clinical and serologic characteristics of systemic lupus erythematosus in the arab world: a pooled analysis of 3,273 patients.","volume":"33","author":"Adwan","year":"2018","journal-title":"Arch Rheumatol"},{"key":"R32-20250918","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1191\/096120398678920389","article-title":"Systemic lupus erythematosus in Kuwait--hospital based study.","volume":"7","author":"Al-Jarallah","year":"1998","journal-title":"Lupus"},{"key":"R33-20250918","first-page":"e20129","article-title":"Determination of the risk factors contributing to the development of neuropsychiatric lupus in a systemic lupus erythematosus cohort.","volume":"13","author":"Bankole","year":"2021","journal-title":"Cureus"},{"key":"R34-20250918","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1002\/art.41876","article-title":"Neuropsychiatric events in systemic lupus erythematosus: predictors of occurrence and resolution in a longitudinal analysis of an international inception cohort.","volume":"73","author":"Hanly","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"R35-20250918","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/rheumatology\/kead297","article-title":"Neuropsychiatric lupus in late- and early-onset systemic lupus erythematosus patients: a systematic review and meta-analysis.","volume":"63","author":"Pamuk","year":"2023","journal-title":"Rheumatology"},{"key":"R36-20250918","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40348-023-00161-7","article-title":"Neuropsychiatric involvement in juvenile-onset systemic lupus erythematosus (jSLE).","volume":"10","author":"Natoli","year":"2023","journal-title":"Mol Cell Pediatr"},{"key":"R37-20250918","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1177\/09612033211045050","article-title":"Neuropsychiatric involvement in juvenile-onset systemic lupus erythematosus: data from the UK Juvenile-onset systemic lupus erythematosus cohort study.","volume":"30","author":"Giani","year":"2021","journal-title":"Lupus"},{"key":"R38-20250918","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.2169\/internalmedicine.9123-21","article-title":"Neuropsychiatric systemic lupus erythematosus with cerebral vasculitis and lupus nephritis successfully treated with high-dose glucocorticoids and mycophenolate mofetil.","volume":"61","author":"Tanaka","year":"2022","journal-title":"Intern Med"},{"key":"R39-20250918","first-page":"e17939","article-title":"Association between hypocomplementemia (C3 and C4) and MRI findings in different neuropsychiatric lupus syndromes in a tertiary hospital.","volume":"13","author":"Bawazir","year":"2021","journal-title":"Cureus"},{"key":"R40-20250918","doi-asserted-by":"crossref","first-page":"839194","DOI":"10.3389\/fnins.2022.839194","article-title":"Structural and functional characterization of gray matter alterations in female patients with neuropsychiatric systemic lupus.","volume":"16","author":"Su","year":"2022","journal-title":"Front Neurosci"},{"key":"R41-20250918","doi-asserted-by":"crossref","first-page":"omx011","DOI":"10.1093\/omcr\/omx011","article-title":"Posterior reversible encephalopathy syndrome (PRES).","volume":"2017","author":"Sudulagunta","year":"2017","journal-title":"Oxf Med Case Reports"},{"key":"R42-20250918","doi-asserted-by":"crossref","first-page":"695888","DOI":"10.3389\/fnins.2022.695888","article-title":"MRI-based classification of neuropsychiatric systemic lupus erythematosus patients with self-supervised contrastive learning.","volume":"16","author":"Inglese","year":"2022","journal-title":"Front Neurosci"},{"key":"R43-20250918","doi-asserted-by":"crossref","first-page":"e000850","DOI":"10.1136\/lupus-2022-000850","article-title":"Clinical outcome in patients with suspected inflammatory neuropsychiatric lupus treated with immunosuppression: an observational cohort study.","volume":"10","author":"Monahan","year":"2023","journal-title":"Lupus Sci Med"},{"key":"R44-20250918","doi-asserted-by":"crossref","first-page":"1189940","DOI":"10.3389\/fpsyt.2023.1189940","article-title":"Antipsychotics reduces mortality in patients with neuropsychiatric systemic lupus erythematosus: a retrospective study of psychiatric consultation cases.","volume":"14","author":"Geng","year":"2023","journal-title":"Front Psychiatry"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000043617","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T22:01:52Z","timestamp":1758232912000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000043617"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,1]]},"references-count":44,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000043617","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,1]]},"assertion":[{"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}